Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme
在法国的一项早期用药计划中，达卡他韦联合索非布韦（可联合或不联合利巴韦林）用于治疗丙型肝炎病毒基因3型感染。
期刊:Liver International
影响因子:5.2
doi:10.1111/liv.13383
Hézode, Christophe; Lebray, Pascal; De Ledinghen, Victor; Zoulim, Fabien; Di Martino, Vincent; Boyer, Nathalie; Larrey, Dominique; Botta-Fridlund, Danielle; Silvain, Christine; Fontaine, Hélène; D'Alteroche, Louis; Leroy, Vincent; Bourliere, Marc; Hubert-Fouchard, Isabelle; Guyader, Dominique; Rosa, Isabelle; Nguyen-Khac, Eric; Fedchuk, Larysa; Akremi, Raoudha; Bennai, Yacia; Filipovics, Anne; Zhao, Yue; Bronowicki, Jean-Pierre
